Loading…
Apyx Medical Corporation is projected to rise to $4.29 by 2027, a +10% move from its current price of $3.90. APYX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.71 | $3.90 | $4.10 | +0.01% |
| May 30 | $3.63 | $3.90 | $4.19 | +0.01% |
| May 31 | $3.58 | $3.90 | $4.26 | +0.02% |
| Jun 1 | $3.53 | $3.90 | $4.31 | +0.03% |
| Jun 2 | $3.49 | $3.90 | $4.37 | +0.03% |
| Jun 3 | $3.45 | $3.90 | $4.41 | +0.04% |
| Jun 4 | $3.42 | $3.90 | $4.46 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.42 | $3.90 | $4.46 | +0.05% |
| Week 2 | $3.23 | $3.90 | $4.71 | +0.09% |
| Week 3 | $3.10 | $3.91 | $4.92 | +0.14% |
| Week 4 | $3.00 | $3.91 | $5.10 | +0.18% |
| Week 5 | $2.90 | $3.91 | $5.26 | +0.23% |
| Week 6 | $2.82 | $3.91 | $5.42 | +0.27% |
| Week 7 | $2.75 | $3.91 | $5.56 | +0.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Apyx Medical Corporation is an energy technology company that designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers a helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
The helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical Corporation trades at $4.13 per share and has a market capitalization of $172.94M. Its market position is reflected by a rank of 3928. The current price and market cap frame a small-cap healthcare stock with a clearly defined multi-segment business model across Surgical Aesthetics and OEM offerings.
The price outlook, based on the provided year-by-year forecast, suggests upside potential over the longer term. The 2026 forecast shows an average around $4.13, with higher annual averages projected into the 2030s and beyond. The long-range forecast points to substantial upside, with the 2030 average near $8.70 and the 2050 average near $42.21, implying meaningful price progression from the current level.
A major floor 45.8% below — a decisive break under it would weaken the trend.
The nearest floor, 28.5% below — buyers have tended to step in here.
The nearest ceiling, 11.8% above — a clean break opens room to run.
A major ceiling 34.7% above — clearing it would confirm fresh momentum.
Key APYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of APYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.03 | Sell | $4.01 | Sell |
| MA 10 | $4.02 | Sell | $3.96 | Sell |
| MA 20 | $3.69 | Buy | $3.86 | Buy |
| MA 50 | $3.75 | Buy | $3.76 | Buy |
| MA 100 | $3.75 | Buy | $3.67 | Buy |
| MA 200 | $3.36 | Buy | $3.33 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.66 | Neutral |
| Stoch RSI (14) | 5.05 | Buy |
| CCI (20) | 35.23 | Neutral |
| Williams %R (14) | -57.50 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 6.27 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 42.50 | Neutral |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 0.27 | Buy |
| Ultimate (7,14,28) | 50.45 | Neutral |
| Momentum (10) | -0.19 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 4.10 | Sell |
| ADX (14) | 15.35 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is bullish overall, with RSI14 at 60 indicating constructive momentum. The near-term trend is supported by the SMA50 at $3.74, above the SMA200 at $3.34, suggesting a positive short-term slope.
Key support is noted at $2.79 and resistance at $4.36, framing a 30-day range of $2.93 to $5.83. This range reflects a fairly wide short-term movement window, underscoring both upside and downside risks within the next month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.79 | $3.90 | $5.27 | 0% | Neutral | |
| $3.12 | $4.29 | $6.36 | +10% | Neutral | |
| $3.08 | $4.46 | $7.01 | +14% | Neutral | |
| $3.23 | $4.91 | $8.08 | +26% | Bullish | |
| $4.77 | $7.57 | $12.94 | +94% | Bullish | |
| $5.27 | $8.71 | $15.37 | +123% | Bullish | |
| $5.12 | $8.79 | $15.97 | +125% | Bullish | |
| $5.38 | $9.59 | $17.88 | +146% | Bullish | |
| $5.18 | $9.57 | $18.28 | +145% | Bullish | |
| $5.10 | $9.75 | $19.04 | +150% | Bullish | |
| $7.71 | $17.13 | $36.64 | +339% | Bullish | |
| $15.54 | $34.54 | $79.44 | +786% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.79 | $3.90 | $4.59 | +0.00% |
| June 2026 | $3.19 | $3.81 | $4.72 | -2.28% |
| July 2026 | $3.23 | $3.92 | $4.97 | +2.94% |
| August 2026 | $3.09 | $3.80 | $4.90 | -3.17% |
| September 2026 | $2.96 | $3.67 | $4.81 | -3.28% |
| October 2026 | $3.09 | $3.88 | $5.15 | +5.66% |
| November 2026 | $3.19 | $4.03 | $5.42 | +3.88% |
| December 2026 | $3.04 | $3.88 | $5.27 | -3.84% |
Click any year to see its month-by-month APYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The APYX price prediction for 2026 points to an average of $3.90 (low $2.79, high $5.27) — a potential gain of 0% on today's $3.90. A consolidation phase looks the most probable path here.
In 2027, APYX is projected to trade between $3.12 and $6.36, averaging $4.29 — a potential gain of +10% from today's $3.90. That is up +10% on the projected 2026 average. Price action looks broadly range-bound.
Apyx Medical Corporation's 2028 outlook centres on $4.46, within a $3.08 to $7.01 range. That is up +4% on the projected 2027 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, APYX could reach as high as $8.08, with a base case around $4.91 and support toward $3.23 — roughly +26% from $3.90. Momentum favours further upside here.
Expect APYX to range from $4.77 to $12.94 through 2030. The $7.57 average target implies a +94% move from current prices. That is up +54% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The APYX price prediction for 2031 points to an average of $8.71 (low $5.27, high $15.37) — a potential gain of +123% on today's $3.90. Momentum favours further upside here.
In 2032, APYX is projected to trade between $5.12 and $15.97, averaging $8.79 — a potential gain of +125% from today's $3.90. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Apyx Medical Corporation's 2033 outlook centres on $9.59, within a $5.38 to $17.88 range. That is up +9% on the projected 2032 average. That marks a +146% change versus current levels. Momentum favours further upside here.
By 2034, APYX could reach as high as $18.28, with a base case around $9.57 and support toward $5.18 — roughly +145% from $3.90. Buyers look set to stay in control over this stretch.
Expect APYX to range from $5.10 to $19.04 through 2035. The $9.75 average target implies a +150% move from current prices. That is up +2% on the projected 2034 average. Momentum favours further upside here.
The APYX price prediction for 2040 points to an average of $17.13 (low $7.71, high $36.64) — a potential gain of +339% on today's $3.90. Buyers look set to stay in control over this stretch.
In 2050, APYX is projected to trade between $15.54 and $79.44, averaging $34.54 — a potential gain of +786% from today's $3.90. That is up +102% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in APYX today (≈ 256.410256 APYX) could be worth
$8,855.79
+$7,855.79 (+786%) by 2050 · US Dollar
Based on the average projected APYX price of $34.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in APYXwould be worth at today's price.
$1,000 invested in APYX on May 27, 2025 (≈ 568.181821 APYX) would be worth
$2,215.91
+$1,215.91 (+121.6%) today · 2.22× · US Dollar
Based on a APYX entry price of $1.76 vs. today's $3.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.79 | $1,029.02 | +2.9% |
| 1 month ago | $3.76 | $1,037.23 | +3.7% |
| 3 months ago | $3.5 | $1,114.29 | +11.4% |
| 6 months ago | $4.01 | $972.57 | -2.7% |
| 1 year ago | $1.76 | $2,215.91 | +121.6% |
| All time (5.0y) ago | $9.84 | $396.34 | -60.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our APYX forecast.
Our base-case forecast reaches $7.80 around 2031.
Implied market cap at $7.80: $326.62M
The multi-year forecast shows a bullish trajectory across the horizon. In 2026, the min, avg, and max are $2.79, $4.13, and $5.60, with an ROI of 0% and a NEUTRAL sentiment. By 2027 the average is $4.63 with a $6.94 high and a 12.2% ROI, maintaining NEUTRAL sentiment.
In 2028 the average climbs to $4.85 (range $3.31-$7.72) with a 17.5% ROI and NEUTRAL sentiment. The 2029 projection strengthens to an average of $5.43 (range $3.52-$9.05) and a 31.5% ROI, turning to BULLISH sentiment.
The long view shows notable upside: 2030 average $8.70 with a max of $15.07 and a 110.6% ROI, followed by continued strength in 2031 ($9.87 avg, $17.68 max, 138.9% ROI), 2032 ($9.90 avg, $18.26 max, 139.6% ROI), and 2033 ($11.11 avg, $21.06 max, 169% ROI). The uptrend persists through 2034 ($10.92 avg, $21.21 max, 164.4% ROI) and 2035 ($11.09 avg, $22.04 max, 168.6% ROI).
Looking further ahead, 2040 delivers a strong expansion with an average of $20.06 ($9.03 min, $43.72 max) and a 385.8% ROI, while 2050 projects an average of $42.21 ($18.99 min, $97.07 max) and a 921.9% ROI, with sentiment remaining BULLISH throughout. These figures are estimates and not guarantees, reflecting potential upside conditional on market conditions and execution.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $8.70, with a low of $5.39 and a high of $15.07, and a ROI of 110.6%. The sentiment is BULLISH.
The projections indicate a path of rising averages and sizable ROIs beyond 2026, including 2027 average $4.63 (ROI 12.2%), 2028 average $4.85 (ROI 17.5%), 2029 average $5.43 (ROI 31.5%), 2030 average $8.70 (ROI 110.6%), 2040 average $20.06 (ROI 385.8%), and 2050 average $42.21 (ROI 921.9%). The 2026 estimate is $4.13 with 0% ROI. These are forecasts and not guarantees.
According to the forecast, the maximum by 2050 is $97.07, which is below $100.
Current price is $4.13 and market capitalization is $172.94M.
The 30-day range is $2.93 to $5.83. The near-term technical picture shows bullish sentiment with RSI 60, SMA50 at $3.74 and SMA200 at $3.34, with support at $2.79 and resistance at $4.36.
Apyx Medical Corporation Community Discussion
0Share your Apyx Medical Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.